Russell Investments Group
JBIO

Russell Investments Group’s Jade Biosciences JBIO Stock Holding History

Russell Investments Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Buy
163,084
+55,488
+52% +$1.16M ﹤0.01% 1716
2026
Q1 		$1.51M Buy
107,596
+101,664
+1,714% +$1.47M ﹤0.01% 2014
2025
Q4 		$91.5K Buy
5,932
+1,510
+34% +$17.7K ﹤0.01% 3073
2025
Q3 		$38.2K Buy
4,422
+1,279
+41% +$10.5K ﹤0.01% 3376
2025
Q2 		$31.4K Buy
3,143
+2,217
+239% +$75.5K ﹤0.01% 3093
2025
Q1 		$81.3K Buy
926
+492
+113% +$43.2K ﹤0.01% 2798
2024
Q4 		$40.2K Buy
434
+228
+111% +$19.6K ﹤0.01% 2872
2024
Q3 		$15.1K Buy
+206
New +$13.3K ﹤0.01% 3012
2024
Q2 		– Hold
0
– -$207 – 3581
2024
Q1 		– Hold
0
– – – 3277
2023
Q3 		– Sell
-27
Closed -$16.1K – 3525
2023
Q2 		$16.1K Hold
27
– – ﹤0.01% 2879
2023
Q1 		$18.9K Sell
27
-7
-21% -$5.81K ﹤0.01% 2820
2022
Q4 		$34.4K Hold
34
– – ﹤0.01% 2760
2022
Q3 		$19K Sell
34
-25
-42% -$16.7K ﹤0.01% 2812
2022
Q2 		$32K Buy
+59
New +$28.2K ﹤0.01% 2757

Other funds holding JBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Russell Investments Group's JBIO Position: Q2 2026 in Review

Russell Investments Group increased its Jade Biosciences (JBIO) stake by 52% in Q2 2026, buying an estimated $1.16M and bringing the position to 163,084 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Russell Investments Group first reported a position in JBIO in Q2 2022 and has held it in 13 quarters since. 40 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Russell Investments Group held 163,084 shares of Jade Biosciences worth $3.62M as of Q2 2026.
  • Russell Investments Group bought 55,488 Jade Biosciences shares in Q2 2026, an estimated $1.16M.
  • Jade Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1716 holding.
  • Russell Investments Group first reported a position in Jade Biosciences in Q2 2022 and has held it in 13 quarters since.
  • 40 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.